Literature DB >> 25212495

Rapid regression of a subset of class 1 uveal melanomas after Iodine-125 plaque radiotherapy suggests an inflammatory mechanism.

Royce W S Chen1, J William Harbour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25212495      PMCID： PMC4246029          DOI： 10.1007/s00417-014-2793-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Relationship between rate of posterior uveal melanoma flattening following plaque radiotherapy and gene expression profile class of tumor cells.

Authors:  Zélia M Corrêa; James J Augsburger
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 2.  Immunity to melanoma antigens: from self-tolerance to immunotherapy.

Authors:  Craig L Slingluff; Kimberly A Chianese-Bullock; Timothy N J Bullock; William W Grosh; David W Mullins; Lisa Nichols; Walter Olson; Gina Petroni; Mark Smolkin; Victor H Engelhard
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

3.  Uveal melanoma: molecular pattern, clinical features, and radiation response.

Authors:  Michael C Chappell; Devron H Char; Tia B Cole; J William Harbour; Kavita Mishra; Vivian K Weinberg; Theodore L Phillips
Journal:  Am J Ophthalmol       Date:  2012-04-27       Impact factor: 5.258

4.  Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Authors:  Michael D Onken; Justis P Ehlers; Lori A Worley; Jun Makita; Yoshifumi Yokota; J William Harbour
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

5.  Post-irradiation regression of choroidal melanomas as a risk factor for death from metastatic disease.

Authors:  J J Augsburger; J W Gamel; J A Shields; A M Markoe; L W Brady
Journal:  Ophthalmology       Date:  1987-09       Impact factor: 12.079

6.  The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma.

Authors:  J William Harbour; Royce Chen
Journal:  PLoS Curr       Date:  2013-04-09
  6 in total
  3 in total

1.  Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.

Authors:  Kishan Gupta; Colin A McCannel; Mitchell Kamrava; James Lamb; Robert D Almanzor; Tara A McCannel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-24       Impact factor: 3.117

Review 2.  The biology of uveal melanoma.

Authors:  Adriana Amaro; Rosaria Gangemi; Francesca Piaggio; Giovanna Angelini; Gaia Barisione; Silvano Ferrini; Ulrich Pfeffer
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

3.  Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment.

Authors:  Bruno Fionda; Monica Maria Pagliara; Valentina Lancellotta; Carmela Grazia Caputo; Calogero Casà; Maria Grazia Sammarco; Elisa Placidi; Patrizia Cornacchione; Francesco Boselli; Roberto Iezzi; Cesare Colosimo; Luca Tagliaferri; Maria Antonietta Blasi
Journal:  J Contemp Brachytherapy       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.